Mc Toxicology Consulting GmbH

Where the EU money came from

Funding by EU programme. Amounts are Mc Toxicology Consulting GmbH's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• iMPactPartner

  Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity

  Horizon Europe · 2021–2023 · Project on CORDIS ↗

  €4ktheir share
• CureCNPartner

  Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €87ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Stichting Amsterdam UmcNetherlands · 1 shared project
• Assistance Publique Hopitaux de ParisFrance · 1 shared project
• Universita Degli Studi di Napoli Federico IiItaly · 1 shared project
• University of LeicesterUnited Kingdom · 1 shared project
• Medizinische Hochschule HannoverGermany · 1 shared project
• Eurice European Research and Project Office GmbHGermany · 1 shared project
• Association GenethonFrance · 1 shared project
• Metriopharm AGSwitzerland · 1 shared project
• Catalyze B.V.Netherlands · 1 shared project
• Genosafe SASFrance · 1 shared project
• Azienda Socio Sanitaria Territoriale Papa Giovanni XxiiiItaly · 1 shared project
• Immunologik GmbHGermany · 1 shared project
• Association Francaise de Crigler NajjarFrance · 1 shared project
• Blust VolkerAustria · 1 shared project
• Metriopharm Deutschland GmbHGermany · 1 shared project
• Fondazione Per la Ricerca Ospedale Maggiore de BergamoItaly · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• coronaviruses
• development studies
• gene therapy
• mortality
• mutation
• pandemics
• vaccines
• virology